[ATX] YoY Quarter Result on 31-Mar-2023 [#Q4]

Stock
[ATX] Amplia Therapeutics Limited
Announcement Date
30-Mar-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q4]
Profit Trend
QoQ- -14.39%
YoY- -43.45%
Quarter Report
ATX's Result
ATX's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 2,004 -580 1,221 674 34 -0 -77 -
PBT -5,364 -2,751 -3,542 -2,444 -1,368 -1,152 -1,802 19.91%
Tax -1,989 580 -1,221 -674 -34 0 0 -
NP -3,374 -3,331 -2,322 -1,770 -1,334 -1,152 -1,802 11.00%
Tax Rate - - - - - - - -
Total Cost 5,379 2,751 3,542 2,444 1,368 1,152 1,725 20.84%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin -168.34 574.35 -190.17 -262.76 -3,898.12 273,022.75 2,337.94 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -0.02 -0.02 -0.01 -0.02 -0.02 -0.03 -0.08 -20.61%
EPS Diluted -0.02 -0.02 -0.01 -0.02 -0.02 -0.03 -0.08 -20.61%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.